Furthermore, high expression of both TMPO-AS1 and TMPO was associated with even worse prognosis, suggesting that the combination of both genes might constitute a more potent prognostic marker in patients with ESCC (Figs. 1, 7). The gene discussed is TMPO; the disease is esophageal squamous cell carcinoma.